Taro Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TARO, and what generic alternatives to TARO drugs are available?
TARO has two hundred and fifty-seven approved drugs.
There are five US patents protecting TARO drugs. There are four tentative approvals on TARO drugs.
There are twenty-four patent family members on TARO drugs in eleven countries and one hundred and ninety supplementary protection certificates in fifteen countries.
Summary for Taro
| International Patents: | 24 |
| US Patents: | 5 |
| Tradenames: | 135 |
| Ingredients: | 118 |
| NDAs: | 257 |
| Patent Litigation for Taro: | See patent lawsuits for Taro |
| PTAB Cases with Taro as petitioner: | See PTAB cases with Taro as petitioner |
Drugs and US Patents for Taro
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | AZITHROMYCIN | azithromycin | FOR SUSPENSION;ORAL | 211521-001 | Dec 11, 2019 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Taro | OXYMETAZOLINE HYDROCHLORIDE | oxymetazoline hydrochloride | CREAM;TOPICAL | 213584-001 | Oct 4, 2021 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Taro | TRIVAGIZOLE 3 | clotrimazole | CREAM;VAGINAL | 021143-001 | Apr 12, 2000 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Taro | FLUPHENAZINE HYDROCHLORIDE | fluphenazine hydrochloride | TABLET;ORAL | 215674-003 | Apr 14, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Taro | HALOBETASOL PROPIONATE | halobetasol propionate | CREAM;TOPICAL | 077227-001 | Aug 4, 2005 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Taro
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 6,656,482 | ⤷ Subscribe |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,399,079 | ⤷ Subscribe |
| Taro | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ⤷ Subscribe |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,102,254 | ⤷ Subscribe |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,071,523 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TARO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
International Patents for Taro Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2007019184 | ⤷ Subscribe |
| Israel | 187666 | ⤷ Subscribe |
| European Patent Office | 1898707 | ⤷ Subscribe |
| New Zealand | 566117 | ⤷ Subscribe |
| European Patent Office | 2630951 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0984957 | 300483 | Netherlands | ⤷ Subscribe | PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYDRAAT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105 |
| 0480717 | 98C0022 | France | ⤷ Subscribe | PRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825 |
| 2203431 | CR 2015 00014 | Denmark | ⤷ Subscribe | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119 |
| 0463756 | SPC/GB99/004 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: SILDENAFIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR THE CITRATE SALT; REGISTERED: CH 54642 19980622; UK EU/1/98/077/001 19980914; UK EU/1/98/077/002 19980914; UK EU/1/98/077/003 19980914; UK EU/1/98/077/004 19980914; UK EU/1/98/077/005 19980914; UK EU/1/98/077/006 19980914; UK EU/1/98/077/007 19980914; UK EU/1/98/077/008 19980914; UK EU/1/98/077/009 19980914; UK EU/1/98/077/010 19980914; UK EU/1/98/077/011 19980914; UK EU/1/98/077/012 19980914 |
| 1499331 | 13C0055 | France | ⤷ Subscribe | PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: BE - 434323 20130220 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
